GABA + AMPA + Ca-channel modulator racetam, anti-amnestic.
The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.
WHAT IS NEFIRACETAM?
Nefiracetam (DM-9384) is a Daiichi Pharmaceutical development built on the Piracetam scaffold with a dimethyl-phenyl-acetyl substituent. It acts at several sites: nicotinic + muscarinic ACh receptor positive modulation (PMID 10869513), NMDA receptor glycine-site modulation (PMID 17095583), sustained opening of L- and N-type voltage-gated Ca²⁺ channels (PMID 10850736), and PKA/PKC signaling cascade amplification (PMID 9443926). Ca²⁺-channel modulation is the primary anti-amnestic mechanism. Anti-excitotoxic profile (protects neurons from glutamate-induced damage). Phase 3 trials (post-stroke apathy, Alzheimer`s) ran in Japan; the NIH USA Phase 2 Alzheimer`s trial was halted over a male-hepatotoxicity signal.
Mechanism
GABA-A + AMPA + L-Ca²⁺
Half-life
~3-5 h
Legal status
Investigational, not approved
Safety
Side effects · 6
Contraindications · 5
Related Nootropics
Telegram
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.